Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome.
about
Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndromeProgress in genetic studies of pain and analgesiaIrritable bowel syndrome: new insights into symptom mechanisms and advances in treatmentIrritable bowel syndrome: Is it "irritable brain" or "irritable bowel"?Genetic epidemiology of irritable bowel syndromeIrritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndromeGenetic polymorphism in pathogenesis of irritable bowel syndromeThe clinical potential of ramosetron in the treatment of irritable bowel syndrome with diarrhea (IBS-D)Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndromeThe role of pelvic floor dysfunction and slow colonic transit in adolescents with refractory constipationHow the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.Polymorphism in the oxytocin promoter region in patients with lactase non-persistence is not related to symptoms.New pathophysiological mechanisms in irritable bowel syndrome.Ramosetron in irritable bowel syndrome with diarrhea: new hope or the same old story?AJG series: molecular biology for clinicians.Genetics and irritable bowel syndrome: from genomics to intermediate phenotype and pharmacogeneticsIrritable bowel syndrome: a review article.A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea.Atypical antipsychotics as a possible treatment option for irritable bowel syndrome.Lubiprostone: evaluation of the newest medication for the treatment of adult women with constipation-predominant irritable bowel syndromeGenetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders.Mitochondrial DNA and gastrointestinal motor and sensory functions in health and functional gastrointestinal disorders.Guidelines on the irritable bowel syndrome: mechanisms and practical management.Alosetron and irritable bowel syndrome.Irritable bowel syndrome: the evolution of multi-dimensional looking and multidisciplinary treatmentsS100A expression and interleukin-10 polymorphisms are associated with ulcerative colitis and diarrhea predominant irritable bowel syndrome.Pilot study of Biomarkers for predicting effectiveness of ramosetron in diarrhea-predominant irritable bowel syndrome: expression of S100A10 and polymorphisms of TPH1Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics.What does irritable bowel syndrome share with non-alcoholic fatty liver disease?Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome.Treating irritable bowel syndrome: overview, perspective and future therapies.Role of serotonin in the pathophysiology of the irritable bowel syndrome.Lessons Learnt from Post-Infectious IBS.Scintigraphic biomarkers for colonic dysmotility.Serotonin receptor 3A polymorphism c.-42C > T is associated with severe dyspepsiaOf actors, bolting horses, and drops in oceans!Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndromeFamilial aggregation of irritable bowel syndrome: a prospective studyAssociation of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders.Pharmacology of serotonin: what a clinician should know.
P2860
Q21195658-7E09CFE7-FCD0-402F-B19B-D9A1EEA2D57AQ24289028-B08D8DF8-96CA-4E3E-B889-1D9196A8E1B4Q26751193-6DF65780-E8E0-433D-9205-84BC490D0247Q26769908-00A939A5-BBF4-4490-B9DC-C4686998723DQ26777392-AE6DA18F-DBD7-4CF0-B05D-80E0CD4247FAQ26860280-78D54355-9620-4171-917B-2338A904439EQ27008164-C680B413-FFA6-4CCF-B38E-66F8B3B03582Q27024521-0F916C62-3944-4D35-BBF4-C05175FA476AQ28072085-772A98E7-5E40-476D-BA93-ADB08FB5F79AQ28276796-DAC387D6-58D8-4B0D-B2D8-0566F9DD3049Q30485725-8914F4FB-5972-499F-ADC1-C0C1A6C8C143Q30924503-CB86911F-95CF-42C6-957E-A47ECF53ACFBQ33432064-EBC26381-626A-42F1-B54B-4E7B0D744C57Q33656496-C1997351-AFA5-4BB5-AE71-2F0BED84DC50Q33984210-1D1D7AB3-C937-4C89-A0BC-5097468DFF1AQ33992299-65ECFE13-67A7-4068-A2DC-A8D1F3F05F6AQ34134491-2A998B85-4069-4207-819E-664120841B95Q34237231-E8EF0069-CFE3-4C7F-9FFA-EF66FD7CD746Q34333642-1603FE5A-3053-48AA-8CBE-7E8059902661Q34345704-0FF7B3FD-6AF2-47B3-9C27-93A69854EA2DQ34473834-93818C0A-134F-4852-A903-8D66A906859DQ34603143-41337231-7905-4128-8073-2654F07548D0Q34626602-6D1D8D17-B202-426A-959C-0BBDE6F227CEQ34649076-DC1EB377-4AC3-40D0-9EC4-BB505E909958Q34660338-E31E5D84-5E5E-4440-AE63-35F169BE7BB6Q34675807-EC8A36FB-30B8-4AF0-BBF6-0D0CDDB83F8EQ34848481-01DC6F24-2B09-4600-968F-A112230A83B5Q34893529-8DBB9362-F682-4B1A-AA86-29408864B5C6Q34983471-D418EB57-819E-44D6-923D-97FD7074C63FQ34992347-2FBF3660-8470-4949-824B-83BD88408A43Q35047051-0723C3C5-9F91-4C34-9C07-79FF0DC9ACB5Q35047066-F5102332-070A-4CCE-BEA9-E731C3F575A7Q35176122-07110ED1-E9FF-4DAD-B645-ACE19D8C309BQ35384517-54D2D5D5-19BF-43C9-8D15-52AC1720129CQ35541477-B8AE8376-E6AC-4518-901C-7A3620FF03ABQ35595593-9860871D-50BC-41D3-A885-865FB308BF44Q35595654-588665B5-C16F-4AFF-BFE4-3F9650AEE781Q35596202-F2F8FF54-E47D-4969-B090-8463E16286E7Q35596567-7B62B3B0-B8B4-49F1-A6A5-7199CE3AF7E3Q35596862-111527AC-19A7-484F-B2DE-33571ECFF8C7
P2860
Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Serotonin-transporter polymorp ...... nant irritable bowel syndrome.
@ast
Serotonin-transporter polymorp ...... nant irritable bowel syndrome.
@en
type
label
Serotonin-transporter polymorp ...... nant irritable bowel syndrome.
@ast
Serotonin-transporter polymorp ...... nant irritable bowel syndrome.
@en
prefLabel
Serotonin-transporter polymorp ...... nant irritable bowel syndrome.
@ast
Serotonin-transporter polymorp ...... nant irritable bowel syndrome.
@en
P2093
P356
P1433
P1476
Serotonin-transporter polymorp ...... nant irritable bowel syndrome.
@en
P2093
Blanca E Viramontes
Elena Atanasova
Paula J Carlson
Raul Urrutia
Sanna McKinzie
Umraan Ahmad
P304
P356
10.1053/GAST.2002.34780
P407
P577
2002-08-01T00:00:00Z